Ahammune Biosciences Private Limited, a active private limited company, was established on 05 May 2016 in Pune, Maharashtra, India. Engaging in biotechnology within the life sciences sector, it holds CIN: U74999PN2016PTC164337. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.85 M and a paid-up capital of ₹0.56 M.
It upholds a compliant status. Its leadership includes Naganand Doraswamy (Director), Tanjore Balganesh Soundararajan (Director), Parul Ganju (Director). Past directors included Uday Chatterjee, Rohan Gobind Rijhwani, Gautham Nadig. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office S1 & S2 Abil Imperial Commercial Spaces, Baner, Pune, Maharashtra, 411045.
U74999PN2016PTC164337
164337
05 May 2016
₹0.85 M
₹0.56 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Ahammune Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naganand Doraswamy | Director | 20 Feb 2021 | Current |
| Tanjore Balganesh Soundararajan | Director | 08 May 2021 | Current |
| Parul Ganju | Director | 05 May 2016 | Current |
| Krishnamurthy Natarajan | Director | 05 May 2016 | Current |
| Roopan Aulakh | Additional Director | 15 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2018 | Past |
| Pramod Abcsdd | Director | 09 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Director | 26 Jan 2020 | Past |
| Pramod Abcsdd | Director | 30 Jul 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ahammune Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.29% increase. The company also saw a substantial improvement in profitability, with a 62.78% increase in profit. The company's net worth dipped by a decrease of 4.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ahammune Biosciences had a public holding of 25.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ahammune Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ahammune Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ahammune Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Roopan Aulakh was appointed as a Additional Director was appointed as a Additional Director on 15 Sep 2025 & has been associated with this company since 2 months 18 days . was completed.
Progress on Ahammune Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Ahammune Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
Progress on Tanjore Balganesh Soundararajan was appointed as a Director was appointed as a Director on 08 May 2021 & has been associated with this company since 4 years 6 months . was documented.
Naganand Doraswamy was appointed as a Director was appointed as a Director on 20 Feb 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.
The activity Parul Ganju was appointed as a Director was appointed as a Director on 05 May 2016 & has been associated with this company since 9 years 6 months . was completed.
The CIN of Ahammune Biosciences Private Limited is U74999PN2016PTC164337.
Ahammune Biosciences Private Limited is headquartered at Office S1 & S2 Abil Imperial Commercial Spaces, Baner, Pune, Maharashtra, 411045.
Ahammune Biosciences Private Limited was incorporated on 05 May 2016.
The current directors of Ahammune Biosciences Private Limited are
The primary industry of Ahammune Biosciences Private Limited is Life Sciences.
Ahammune Biosciences Private Limited is unlisted.
The authorized capital of Ahammune Biosciences Private Limited is ₹0.85 M, and the paid-up capital is ₹0.56 M.
The compliance status of Ahammune Biosciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX